ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour
Badreddin Edris, Iñigo Espinosa, Thomas Mühlenberg, Amanda Mikels, Cheng-Han Lee, Sonja E Steigen, Shirley Zhu, Kelli D Montgomery, Alexander JF Lazar, Dina Lev, Jonathan A Fletcher, Andrew H Beck, RoVolume:
227
Year:
2012
Language:
english
Pages:
11
DOI:
10.1002/path.3986
File:
PDF, 8.85 MB
english, 2012